Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism

C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis

(2019) Xiaohui Qiu et al.   Frontiers in Neurology

New Guidelines for Statistical Reporting in the Journal

(2019) David Harrington et al.   NEW ENGLAND JOURNAL OF MEDICINE

De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans

(2019) Tobias Deuse et al.   NATURE BIOTECHNOLOGY

Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters

(2018) Marco Del Giudice et al.   BRAIN BEHAVIOR AND IMMUNITY

Genotype-Phenotype Relations for the Parkinson's Disease Genes Parkin , PINK1 , DJ1: MDSGene Systematic Review

(2018) Meike Kasten et al.   MOVEMENT DISORDERS

Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases

(2018) Serge Grazioli et al.   Frontiers in Immunology

Parkin and PINK1 mitigate STING-induced inflammation

(2018) Danielle A. Sliter et al.   NATURE

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

(2018) Zhenyu Zhong et al.   NATURE

The role of monogenic genes in idiopathic Parkinson’s disease

(2018) Xylena Reed et al.   NEUROBIOLOGY OF DISEASE

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

(2017) Susanne A. Schneider et al.   MOVEMENT DISORDERS

Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism

(2016) Andreas Puschmann et al.   BRAIN

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease

(2016) Christian Lood et al.   NATURE MEDICINE

Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study

(2016) Monika Puzianowska-Kuźnicka et al.   Immunity & Ageing

Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease

(2016) Xiao-Yan Qin et al.   JAMA Neurology

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease

(2015) Angela Pyle et al.   ANNALS OF NEUROLOGY

The blood-brain barrier in neuroimmunology: Tales of separation and assimilation

(2015) W.A. Banks   BRAIN BEHAVIOR AND IMMUNITY

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Heterozygote carriers for CNVs inPARK2are at increased risk of Parkinson's disease

(2015) Johanna Huttenlocher et al.   HUMAN MOLECULAR GENETICS

Inflammation is genetically implicated in Parkinson’s disease

(2015) N. Dzamko et al.   NEUROSCIENCE

Triplex real-time PCR–an improved method to detect a wide spectrum of mitochondrial DNA deletions in single cells

(2015) Karolina A. Rygiel et al.   Scientific Reports

Tofacitinib versus Methotrexate in Rheumatoid Arthritis

(2014) Eun Bong Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-6 in Inflammation, Immunity, and Disease

(2014) T. Tanaka et al.   Cold Spring Harbor Perspectives in Biology

Simultaneous quantification of mitochondrial DNA copy number and deletion ratio: A multiplex real-time PCR assay

(2014) Nicole R. Phillips et al.   Scientific Reports

Next-Generation Phenotyping Using theParkinExample

(2013) Anne Grünewald et al.   JAMA Neurology

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

(2012) Alastair J. Noyce et al.   ANNALS OF NEUROLOGY

Cohort Profile: A population-based cohort to study non-motor symptoms in parkinsonism (EPIPARK)

(2012) Meike Kasten et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Systematic Review and UK-Based Study ofPARK2 (parkin), PINK1, PARK7 (DJ-1)andLRRK2in early-onset Parkinson's disease

(2012) Laura L. Kilarski et al.   MOVEMENT DISORDERS

Calibration of unified Parkinson's disease rating scale scores toMovementDisorder Society-unified Parkinson's disease rating scale scores

(2012) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Mitochondrial Quality Control Mediated by PINK1 and Parkin: Links to Parkinsonism

(2012) D. Narendra et al.   Cold Spring Harbor Perspectives in Biology

Olfaction in Parkin heterozygotes and compound heterozygotes: The CORE-PD study

(2010) R. N. Alcalay et al.   NEUROLOGY

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

(2009) Etienne C Hirsch et al.   LANCET NEUROLOGY

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

(2008) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES